The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma.
第一作者:
Kai,Rejeski
第一单位:
Department of Medicine III - Hematology/Oncology, LMU University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany. kai.rejeski@med.uni-muenchen.de.
作者:
主题词
人类(Humans);多发性骨髓瘤(Multiple Myeloma);B细胞成熟抗原(B-Cell Maturation Antigen);预后(Prognosis);回顾性研究(Retrospective Studies);免疫疗法, 过继(Immunotherapy, Adoptive)
DOI
10.1186/s13045-023-01465-x
PMID
37525244
发布时间
2024-06-19
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文